These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 11206631)

  • 1. Assessment of the predictive value of clinical and histopathological factors as well as the immunoexpression of p53 and bcl-2 proteins in response to preoperative chemotherapy for esophageal squamous cell carcinoma.
    Szumilo J; Chibowski D; D browski A
    Dis Esophagus; 2000; 13(3):191-7. PubMed ID: 11206631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
    Nakashima S; Natsugoe S; Matsumoto M; Kijima F; Takebayashi Y; Okumura H; Shimada M; Nakano S; Kusano C; Baba M; Takao S; Aikou T
    Anticancer Res; 2000; 20(3B):1933-7. PubMed ID: 10928129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P; Temam S; Charlotte F; Lacau-St-Guily J
    Br J Cancer; 2002 Dec; 87(12):1390-5. PubMed ID: 12454767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-operative chemotherapy for squamous cell carcinoma of the oesophagus: do histological assessment and p53 overexpression predict chemo-responsiveness?
    Lam KY; Law S; Ma LT; Ong SK; Wong J
    Eur J Cancer; 1997 Jul; 33(8):1221-5. PubMed ID: 9301446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p53 and bcl-2 and response to preoperative chemotherapy and radiotherapy for locally advanced squamous cell carcinoma of the oesophagus.
    Puglisi F; Di Loreto C; Panizzo R; Avellini C; Fongione S; Cacitti V; Beltrami CA
    J Clin Pathol; 1996 Jun; 49(6):456-9. PubMed ID: 8763257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of preoperative chemotherapy on metastatic lymph nodes in esophageal squamous cell carcinoma.
    Tsuchiya Y; Onda M; Sasajima K; Yamashita K; Nomura T; Makino H; Maruyama H; Hagiwara N; Takubo K; Miyashita M
    Dis Esophagus; 2002; 15(3):226-31. PubMed ID: 12444995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
    Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
    Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy.
    Yano M; Shiozaki H; Tsujinaka T; Inoue M; Doki Y; Fujiwara Y; Monden M
    J Am Coll Surg; 2000 Dec; 191(6):626-34. PubMed ID: 11129811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative chemotherapy vs chemoradiotherapy for thoracic esophageal cancer: a prospective randomized clinical trial.
    Tachibana M; Yoshimura H; Kinugasa S; Shibakita M; Dhar DK; Ueda S; Fujii T; Nagasue N
    Eur J Surg Oncol; 2003 Sep; 29(7):580-7. PubMed ID: 12943623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers.
    Kishi K; Doki Y; Yano M; Yasuda T; Fujiwara Y; Takiguchi S; Kim S; Higuchi I; Monden M
    Clin Cancer Res; 2003 Oct; 9(12):4368-75. PubMed ID: 14555508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53, bcl-2, and bax as predictors of response to radiotherapy in esophageal cancer.
    Shimoji H; Miyazato H; Nakachi A; Kuniyoshi S; Isa T; Shiraishi M; Muto Y; Toda T
    Dis Esophagus; 2000; 13(3):185-90. PubMed ID: 11206630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
    Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic nomogram for previously untreated patients with esophageal squamous cell carcinoma after esophagectomy followed by adjuvant chemotherapy.
    Duan J; Deng T; Ying G; Huang D; Zhang H; Zhou L; Bai M; Li H; Yang H; Qu Y; Wang X; Ba Y
    Jpn J Clin Oncol; 2016 Apr; 46(4):336-43. PubMed ID: 26819278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Factors in Patients Receiving Neoadjuvant 5-Fluorouracil plus Cisplatin for Advanced Esophageal Cancer (JCOG9907).
    Yokota T; Ando N; Igaki H; Shinoda M; Kato K; Mizusawa J; Katayama H; Nakamura K; Fukuda H; Kitagawa Y
    Oncology; 2015; 89(3):143-51. PubMed ID: 25895447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 Protein accumulation as a prognostic marker of preoperative radiotherapy and/or chemotherapy in advanced squamous cell esophageal carcinoma--preliminary report.
    Nasierowska-Guttmejer A; Szawłowski A; Jastrzebska M; Jeziorski K; Radziszewski J
    Dis Esophagus; 1999; 12(2):128-31. PubMed ID: 10466045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Presence of Serum p53 Antibody Predicts the Pathological Tumor Response to Neoadjuvant Chemotherapy with Docetaxel, Cisplatin and Fluorouracil (DCF) in Esophageal Squamous Cell Carcinoma.
    Hiyoshi Y; Yoshida N; Watanabe M; Kurashige J; Baba Y; Sakamoto Y; Baba H
    World J Surg; 2017 Feb; 41(2):480-486. PubMed ID: 27637603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
    Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological response of cisplatin predicts patients' survival in oesophageal cancer and p53 protein accumulation in pretreatment biopsy is associated with cisplatin sensitivity.
    Shimada Y; Watanabe G; Yamasaki S; Maeda M; Kawabe A; Kaganoi JI; Itami A; Fukumoto M; Kanda Y; Imamura M
    Eur J Cancer; 2000 May; 36(8):987-93. PubMed ID: 10885602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.